Hesse

DGAP-News: RHÖN-KLINIKUM AG looks back on successful financial year 2021

Retrieved on: 
Friday, April 1, 2022
EBITDA, 2009 Davis Cup, Company, Asclepius, Giessen, Investment, Group, University, Legislation, Board, Letter, MVZ, Education, Research, Hospital, Workload, Nursing, Investor, Hesse, Consolidated, Federalism, Person, Hope, Intention, COVID-19, DRG, Patient, Partnership, Medicine, Health insurance

For RHN-KLINIKUM AG, financial year 2021 was also marked by the COVID-19 pandemic and a big test of its strength and resilience.

Key Points: 
  • For RHN-KLINIKUM AG, financial year 2021 was also marked by the COVID-19 pandemic and a big test of its strength and resilience.
  • In financial year 2021, revenues grew by 3.1 per cent to reach 1.4 billion.
  • For the current financial year, we expect revenues of 1.4 billion euros within a range of plus or minus 5 per cent.
  • RHN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.

P&G Opens New Global Product Supply Innovation Center in Kronberg, Germany to Innovate on Sustainable Supply Chains of the Future

Retrieved on: 
Thursday, June 17, 2021
Supply chain management, Cosmetics, Online Retail, Retail, Environment, Supermarket, States of Germany, Environmentalism, Hochtaunuskreis, Kronberg im Taunus, Sustainability, Hesse, Supply chain, Kronberg (Taunus) station, Articles

Establishing the Kronberg PSIC in this environment enables P&G to build a more resilient, future-proof supply chain.

Key Points: 
  • Establishing the Kronberg PSIC in this environment enables P&G to build a more resilient, future-proof supply chain.
  • The market also offers a rich ecosystem for future partnerships with research institutes, businesses, universities, and other thought leading stakeholders in the Rhine-Main region.
  • With the opening of our Product Supply Innovation Center (PSIC) we hope to inspire change beyond the Rhine-Main-region, Germany and our company and help improve and redefine global processes for production, logistics and retail.
  • Our new product supply innovation center (PSIC) in Kronberg is a key milestone for P&G to accelerate achieving our Ambition 2030 sustainability objectives.

Indivumed Launches the nRavel™ AI Platform for Cancer Research and Drug Development

Retrieved on: 
Wednesday, June 2, 2021
Merck Group, Merck, States of Germany, Brands, Hesse, Abituzumab, Serono

HAMBURG, Germany, June 2, 2021 /PRNewswire/ --Indivumed GmbH ("Indivumed") today announced the launch of nRavelTM, a unique AI discovery platform for oncology and precision medicine.

Key Points: 
  • HAMBURG, Germany, June 2, 2021 /PRNewswire/ --Indivumed GmbH ("Indivumed") today announced the launch of nRavelTM, a unique AI discovery platform for oncology and precision medicine.
  • Most recently, Merck KGaA, Darmstadt, Germany signed a master collaboration agreement with Indivumed to utilize nRavel's capabilities for the company's drug development activities.
  • "The nRavelTM platform puts Indivumed ahead of all other AI-driven drug development platforms.
  • "We look forward to partnering with Merck KGaA, Darmstadt, Germany, who recognized our nRavelTM platform as an exciting new solution for drug development."

EMD Electronics Creates Center of Excellence for Atomic Engineering by Combining Thin Films R&D Lab with Intermolecular

Retrieved on: 
Tuesday, May 4, 2021
Merck Group, States of Germany, Merck, Darmstadt, Hesse, Germany

b'SAN JOSE, Calif., May 4, 2021 /PRNewswire/ -- EMD Electronics, a business of Merck KGaA, Darmstadt, Germany, today announced the creation of a Center of Excellence for atomic engineering at Intermolecular\'s San Jose facility.

Key Points: 
  • b'SAN JOSE, Calif., May 4, 2021 /PRNewswire/ -- EMD Electronics, a business of Merck KGaA, Darmstadt, Germany, today announced the creation of a Center of Excellence for atomic engineering at Intermolecular\'s San Jose facility.
  • The capabilities of EMD Electronics\' Thin-Films Applications R&D lab have been merged with Intermolecular\'s advanced electronics capabilities to create a centralized innovation hub for our customers.
  • Intermolecular, Inc. ("Intermolecular") is the trusted partner for materials innovation and a wholly-owned subsidiary of the EMD Electronics business of Merck KGaA, Darmstadt, Germany.\nEMD Electronics is the North America electronics business of Merck KGaA, Darmstadt, Germany.
  • Today, EMD Electronics has approximately 2,000 employees around the country with regional offices in Tempe (AZ) and Philadelphia (PA).

EMD Performance Materials announces further investments of electronics business and new name: EMD Electronics

Retrieved on: 
Thursday, March 4, 2021
Merck Group, States of Germany, Merck, Darmstadt, Hesse, Germany

TEMPE, Ariz., March 4, 2021 /PRNewswire/ -- EMD Performance Materials today announced an expanded focus on the US electronics business and a new name in the US: EMD Electronics.

Key Points: 
  • TEMPE, Ariz., March 4, 2021 /PRNewswire/ -- EMD Performance Materials today announced an expanded focus on the US electronics business and a new name in the US: EMD Electronics.
  • EMD Electronics, a business of Merck KGaA, Darmstadt, Germany, includes a broad portfolio of semiconductor materials, semiconductor delivery systems and services, display, and surface solutions.
  • This announcement follows the $22 million investment at the EMD Electronics site in Tempe, Arizona for its R&D and production for semiconductor materials announced in February.
  • EMD Electronics is the North America electronics business of Merck KGaA, Darmstadt, Germany.

DGAP-News: publity AG: Commercial property sold in Bad Homburg with Deutsche Bahn as main tenant

Retrieved on: 
Wednesday, March 3, 2021
States of Germany, Hesse-Nassau, Hesse, Bad Homburg vor der Höhe, Hochtaunuskreis, Frankfurt, Homburg (Saar) Hauptbahnhof, Taunus, Rhine-Main S-Bahn, Transport in Frankfurt

Frankfurt, 03.03.2021- publity AG (Scale, ISIN DE0006972508, "publity") has successfully sold an office property in Bad Homburg in its position as asset manager.

Key Points: 
  • Frankfurt, 03.03.2021- publity AG (Scale, ISIN DE0006972508, "publity") has successfully sold an office property in Bad Homburg in its position as asset manager.
  • The office building provides a total lettable area of just under 5,200 square metres and is situated in a centrally located commercial area of Bad Homburg, just outside Frankfurt/Main.
  • publity acquired the property in 2017 and has since successfully developed it; the main tenants include Deutsche Bahn and a major air conditioning manufacturer.
  • The office property is in the asset portfolio of GORE German Office Real Estate AG (ISIN DE000A0Z26C8), an indirect subsidiary of publity AG.

Artios and Merck KGaA announce global strategic collaboration

Retrieved on: 
Thursday, December 3, 2020
Merck Group, States of Germany, Companies, Darmstadt, Hesse, Merck, Merck Serono, Merck & Co.

In 2019, Merck KGaA, Darmstadt, Germany generated sales of 16.2 billion in 66 countries.

Key Points: 
  • In 2019, Merck KGaA, Darmstadt, Germany generated sales of 16.2 billion in 66 countries.
  • Scientific exploration and responsible entrepreneurship have been key to Merck KGaA, Darmstadt, Germany's technological and scientific advances.
  • This is how Merck KGaA, Darmstadt, Germany has thrived since its founding in 1668.
  • Merck KGaA, Darmstadt, Germany holds the global rights to the Merck KGaA, Darmstadt, Germany name and brand.

Flagship Pioneering Announces Appointment of Dr. Luciano Rossetti as New Chief Medical Officer

Retrieved on: 
Monday, November 16, 2020
Merck Group, Darmstadt, Merck, States of Germany, Germany, Hesse

CAMBRIDGE, Mass., Nov. 16, 2020 /PRNewswire/ --Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has strengthened its executive leadership team with the appointment of Luciano Rossetti, MD, as Chief Medical Officer (CMO) as well as the company's first Head of Research & Development (R&D) for its newly formed initiative Pioneering Medicines.

Key Points: 
  • CAMBRIDGE, Mass., Nov. 16, 2020 /PRNewswire/ --Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has strengthened its executive leadership team with the appointment of Luciano Rossetti, MD, as Chief Medical Officer (CMO) as well as the company's first Head of Research & Development (R&D) for its newly formed initiative Pioneering Medicines.
  • "I am delighted to announce the appointment of Luciano Rossetti to Flagship Pioneering's newly created dual leadership roles as Head of R&D for Pioneering Medicines (PM) and Chief Medical Officer for Flagship Pioneering," said Noubar Afeyan, PhD., Founder and CEO of Flagship Pioneering.
  • "I am looking forward to joining Flagship Pioneering, a proven engine for breakthrough innovation in life sciences and medicine," said Dr. Rossetti.
  • Dr. Rossetti comes to Flagship after finishing a six-year tenure as Global Head of Research & Development at Merck KGaA, Darmstadt, Germany.

DGAP-News: Coreo AG continues expansion

Retrieved on: 
Monday, September 28, 2020
Frankfurt, Hesse-Nassau, Nomenclature of Territorial Units for Statistics, Hesse

Frankfurt am Main - 28 September 2020 - By acquiring a logistics property in Haloch, Rhineland-Palatinate, Coreo continues its expansion course.

Key Points: 
  • Frankfurt am Main - 28 September 2020 - By acquiring a logistics property in Haloch, Rhineland-Palatinate, Coreo continues its expansion course.
  • The overall investment will amount to EUR 3.4 million, including the planned investments in technical building equipment.
  • Furthermore, Coreo acquired a plot of land of around 12,000 sqm in Wiesbaden, the state capital of Hesse.
  • Coreo AG, with headquarters in Frankfurt am Main, is a portfolio developer with a focus on German commercial and residential real estate.

Wisper Chooses Calix Revenue EDGE to Drive Over 400 Percent Subscriber Growth Over Five Years

Retrieved on: 
Tuesday, August 4, 2020
Networks, Internet, Data management, Technology, Software, Calix, Wisper, Stooke, Hesse, Geography of Germany, Subdivisions of Germany

Calix, Inc. (NYSE: CALX) today announced Wisper Internet has selected Calix and the Revenue EDGE solution to help grow its subscriber base by more than 400 percent after conducting extensive competitive analysis and solution testing.

Key Points: 
  • Calix, Inc. (NYSE: CALX) today announced Wisper Internet has selected Calix and the Revenue EDGE solution to help grow its subscriber base by more than 400 percent after conducting extensive competitive analysis and solution testing.
  • Wisper recognizes that the Revenue EDGE from Calix is the best option on the market to help execute a full-scale business transformation by delivering the ultimate subscriber experience.
  • Through our evaluation, there were a lot of things that stood out about Calix, said Nathan Stooke, CEO of Wisper.
  • The Revenue EDGE solution allows us to help Wisper raise the bar for the subscriber experience, capture critical market insights, and innovate at a rapid pace.